An award-winning cannabis podcast for women, by women. Hear joyful stories and useful advice about cannabis for health, well-being, and fun—especially for needs specific to women like stress, sleep, and sex. We cover everything from: What’s the best weed for sex? Can I use CBD for menstrual cramps? What are the effects of the Harlequin strain or Gelato strain? And, why do we prefer to call it “cannabis” instead of “marijuana”? We also hear from you: your first time buying legal weed, and how ...
…
continue reading
Content provided by The Cole Memo and Cole Preston. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Cole Memo and Cole Preston or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
#229 - FDA’s MDMA Letter Goes Public, MAPS Responds in Press Conference
MP3•Episode home
Manage episode 504667810 series 2934556
Content provided by The Cole Memo and Cole Preston. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Cole Memo and Cole Preston or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode, we mainly watch the live MAPS press conference that I was invited to, where leadership addressed the FDA’s newly released complete response letter rejecting MDMA assisted therapy for PTSD. You’ll hear their perspective on shifting standards, trial design disputes, and what this decision means for the future of psychedelic medicine. To set the stage, I begin with a clip from Hamilton Morris on drug journalism and the FDA’s rejection of MDMA therapy, then we tune into the full press conference. Links to the FDA letter, my article covering the decision, and outside analysis are included in the show notes. Watch video version and read full show notes here: https://thecolememo.com/2025/09/05/maps-fda/
…
continue reading
563 episodes
MP3•Episode home
Manage episode 504667810 series 2934556
Content provided by The Cole Memo and Cole Preston. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Cole Memo and Cole Preston or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this episode, we mainly watch the live MAPS press conference that I was invited to, where leadership addressed the FDA’s newly released complete response letter rejecting MDMA assisted therapy for PTSD. You’ll hear their perspective on shifting standards, trial design disputes, and what this decision means for the future of psychedelic medicine. To set the stage, I begin with a clip from Hamilton Morris on drug journalism and the FDA’s rejection of MDMA therapy, then we tune into the full press conference. Links to the FDA letter, my article covering the decision, and outside analysis are included in the show notes. Watch video version and read full show notes here: https://thecolememo.com/2025/09/05/maps-fda/
…
continue reading
563 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.